Search results
Pfizer prioritizes the health and well-being of people and the planet to deliver breakthroughs around the world in a responsible way. Learn more in Pfizer’s 2023 Impact Report
- Careers
Depending on the customs and laws of a specific country,...
- Products
In this section find an overview of our Pfizer Products and...
- Contact Us
Pfizer Inc. 66 Hudson Boulevard East New York, NY 10001-2192...
- Newsroom
Pfizer surveyed adults in 10 countries across the Global...
- Executives
Terramycin also marks the beginning of the Pfizer...
- Announcements
02.23.2024 Diversity & Inclusion Employees Responsibility...
- Updates and Statements
10.25.2023 Vaccines Pfizer’s PENBRAYA™ Receives...
- About
Pfizer purchases a nearby vacant ice plant, and employees...
- Careers
News about Pfizer, operational efficiencies, savings
News about Moderna, bird flu, Pfizer
News about Pfizer, technical setup, 200-day moving average
Also in the news
Dec 11, 2020 · COMIRNATY is the first COVID-19 vaccine to be granted FDA approval. Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose. More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020.
Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology.
- c. 83,000 (2022)
- 1849; 174 years ago in New York City
- US$100.3 billion (2022)
- The Spiral, New York City, U.S.
Pfizer is a leading developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs, treatments for rare diseases, and vaccines.
Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the Pfizer-BioNTech COVID-19 Vaccine for individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age whose ...
Aug 23, 2021 · FDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease...
Sep 11, 2023 · The Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19.